| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $1.68 ▲ +2.03% | Yesterday | $1.64 ▼ -0.85% | Tomorrow's Cardiff Oncology Inc. Common Stock (CRDF) setup is anchored to $1.65 and targets $1.68 (+2.03%). The near-term read is upside; watch $1.70 / $1.60 because daily realized volatility is about 8.00%. |
Tomorrow's Cardiff Oncology Inc. Common Stock (CRDF) setup is anchored to $1.65 and targets $1.68 (+2.03%). The near-term read is upside; watch $1.70 / $1.60 because daily realized volatility is about 8.00%. | ||||
| Week | $1.75 ▲ +6.31% | Last Week | $1.61 ▼ -2.65% | The 7-day Cardiff Oncology Inc. Common Stock model moves from $1.61 to $1.75 (+6.31%). It gives upside momentum context for this stock, so breaks around $1.70 / $1.60 matter more than a single tick. |
The 7-day Cardiff Oncology Inc. Common Stock model moves from $1.61 to $1.75 (+6.31%). It gives upside momentum context for this stock, so breaks around $1.70 / $1.60 matter more than a single tick. | ||||
| Month | $1.87 ▲ +13.45% | Last Month | $1.56 ▼ -5.65% | The 1-month Cardiff Oncology Inc. Common Stock target is $1.87 (+13.45%), compared with the live reference near $1.65. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Cardiff Oncology Inc. Common Stock target is $1.87 (+13.45%), compared with the live reference near $1.65. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $2.05 ▲ +24.14% | Last Year | $1.48 ▼ -10.14% | The 1-year Cardiff Oncology Inc. Common Stock scenario points to $2.05 (+24.14%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Cardiff Oncology Inc. Common Stock scenario points to $2.05 (+24.14%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $2.46 ▲ +49.20% | 5 Years Ago | $1.31 ▼ -20.66% | The 5-year Cardiff Oncology Inc. Common Stock view is $2.46 (+49.20%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Cardiff Oncology Inc. Common Stock view is $2.46 (+49.20%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $1.65 | Mid |
| Daily Change | -7.30% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 73% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $1.65 | Daily Change | -7.30% |
| Market Cap | $112.80M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.